Does radiotherapy still have a role in stage III NSCLC in the era of immunotherapy? The radiotherapist’s view

Date 29 September 2019
Event ESMO 2019 Congress
Session Immunotherapy in thoracic malignancies: What has been achieved in 2019?
Topics Tumour Immunology
Complications/Toxicities of Treatment
Radiation Oncology
Presenter Kevin Franks
Authors K. Franks
  • /US